Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by investderpon Jul 08, 2011 11:31pm
330 Views
Post# 18813481

BNC attending Biotech Bioshares Summit 2011, NZ

BNC attending Biotech Bioshares Summit 2011, NZSee details at https://www.bioshares.com.au/queenstown2011.htm

The 7th Bioshares Biotech Summit is being held on Friday22 - Saturday 23 July, 2011. The conference is organisedby Bioshares, Australia's leading independent biotechinvestment publication. The conference is being heldwith the support of New Zealand Trade &Enterprise.

Aconference program will be released in May. Once againit will be packed with around 10 hours of stimulatingconference sessions to discuss the key themes of Australianbiotech and to hear from some of Australia's leadingand most exciting biotech companies. The ConferenceProgram is now available.



Saturday, July 23rd 8:50am

Using Cash Flow Businessesto Fund Higher Margin Products
For many biotechs, cash flow businesses have been establishedand funds from these operations are being used to fundthe commercialization of higher margin products. Delegateswill hear from a number of biotechs that continue to investin products and climb the margin chain.
- Esra Ogru,CEO of Phosphagenics, &PaulGavin
-PaulMacLeman,CEO of Genetic Technologies
- Graeme McRae,CEO of Bionich
Bullboard Posts